Filtros de búsqueda

Lista de obras de Lars Hvilsted Rasmussen

'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey

artículo científico publicado en 2014

'Real-world' management and outcomes of patients with paroxysmal vs. non-paroxysmal atrial fibrillation in Europe: the EURObservational Research Programme-Atrial Fibrillation (EORP-AF) General Pilot Registry

artículo científico publicado en 2016

A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry

artículo científico publicado en 2013

Added predictive ability of the CHA2DS2VASc risk score for stroke and death in patients with atrial fibrillation: the prospective Danish Diet, Cancer, and Health cohort study

artículo científico publicado en 2012

Alcohol intake and prognosis of atrial fibrillation

artículo científico publicado en 2013

Antiplatelet agents for the treatment and prevention of atherothrombosis

artículo científico

Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation

artículo científico publicado en 2015

Atrial fibrillation patients categorized as "not for anticoagulation" according to the 2014 Canadian Cardiovascular Society algorithm are not "low risk".

artículo científico publicado en 2014

Atrial flutter and thromboembolic risk: a systematic review

artículo científico

Blood pressure and prognosis in patients with incident heart failure: the Diet, Cancer and Health (DCH) cohort study

artículo científico publicado en 2015

Body mass index and adverse events in patients with incident atrial fibrillation

artículo científico publicado en 2013

Clopidogrel: background information and use in clinical practice

artículo científico publicado en 2003

Corrigendum: Glomerular filtration rate in patients with atrial fibrillation and 1-year outcomes

artículo científico publicado en 2017

Diabetes mellitus and risk of ischemic stroke in patients with heart failure and no atrial fibrillation

artículo científico publicado en 2016

Duration of Diabetes Mellitus and Risk of Thromboembolism and Bleeding in Atrial Fibrillation: Nationwide Cohort Study

artículo científico publicado en 2015

Female sex as a risk factor for thromboembolism and death in patients with incident atrial fibrillation. The prospective Danish Diet, Cancer and Health study

artículo científico publicado en 2014

Fish, marine n-3 polyunsaturated fatty acids and coronary heart disease: a minireview with focus on clinical trial data

artículo científico publicado en 2006

General mechanisms of coagulation and targets of anticoagulants (Section I). Position Paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart Disease.

artículo científico publicado en 2013

Glomerular filtration rate in patients with atrial fibrillation and 1-year outcomes

scientific article published on 28 July 2016

Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry

artículo científico publicado en 2015

Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation

artículo científico publicado en 2012

Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Gro

artículo científico publicado en 2014

Marine n-3 polyunsaturated fatty acids and coronary heart disease. Part I. Background, epidemiology, animal data, effects on risk factors and safety

artículo científico publicado en 2005

Marine n-3 polyunsaturated fatty acids in adipose tissue and the risk of acute coronary syndrome

artículo científico publicado en 2011

Myocardial ischemic events in 'real world' patients with atrial fibrillation treated with dabigatran or warfarin

artículo científico publicado en 2013

New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease position paper

artículo científico publicado en 2012

Non-vitamin K antagonist oral anticoagulants and the treatment of venous thromboembolism in cancer patients: a semi systematic review and meta-analysis of safety and efficacy outcomes

artículo científico publicado en 2014

Oral anticoagulants in coronary heart disease (Section IV). Position paper of the ESC Working Group on Thrombosis - Task Force on Anticoagulants in Heart Disease

artículo científico publicado en 2016

Oral anticoagulation, aspirin, or no therapy in patients with nonvalvular AF with 0 or 1 stroke risk factor based on the CHA2DS2-VASc score

artículo científico publicado en 2015

Pre-existing atrial fibrillation and risk of arterial thromboembolism and death following pneumonia: a population-based cohort study

artículo científico publicado en 2014

Pre-existing atrial fibrillation and risk of arterial thromboembolism and death in intensive care unit patients: a population-based cohort study

artículo científico publicado en 2015

Prevention of venous thromboembolism with new oral anticoagulants versus standard pharmacological treatment in acute medically ill patients: a systematic review and meta-analysis

artículo científico publicado en 2012

Primary and secondary prevention with new oral anticoagulant drugs for stroke prevention in atrial fibrillation: indirect comparison analysis

artículo científico publicado en 2012

Prognosis and treatment of atrial fibrillation patients by European cardiologists: one year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot registry).

artículo científico publicado en 2014

Renal function and non-vitamin K oral anticoagulants in comparison with warfarin on safety and efficacy outcomes in atrial fibrillation patients: a systemic review and meta-regression analysis

artículo científico publicado en 2014

Reply: Dabigatran's 'real-world' data about risk of myocardial infarction and gastrointestinal bleeding contradicts with randomized trials

artículo científico publicado en 2013

Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and Bleeding: A Nationwide Cohort Study

artículo científico publicado en 2015

Seasonality, incidence and prognosis in atrial fibrillation and stroke in Denmark and New Zealand

artículo científico publicado en 2012

Stroke and mortality in patients with incident heart failure: the Diet, Cancer and Health (DCH) cohort study

artículo científico publicado en 2012

The impact of smoking on thromboembolism and mortality in patients with incident atrial fibrillation: insights from the Danish Diet, Cancer, and Health study

artículo científico publicado en 2014

Use of psychotropic drugs following venous thromboembolism in youth. A nationwide cohort study

artículo científico publicado en 2015

Using the CHA2DS2-VASc Score for Stroke Prevention in Atrial Fibrillation: A Focus on Vascular Disease, Women, and Simple Practical Application

artículo científico publicado en 2015

Vascular Disease and Risk Stratification for Ischemic Stroke and All-Cause Death in Heart Failure Patients without Diagnosed Atrial Fibrillation: A Nationwide Cohort Study

artículo científico publicado en 2016

Vitamin K antagonists in heart disease: current status and perspectives (Section III). Position paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart Disease

scientific article published on 14 November 2013

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda